An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Roger Hesselstrand, Jörg H.W. Distler, Gabriela Riemekasten, Dirk M. Wuttge, Marie Törngren, Helén C. Nyhlén, Fredrik Andersson, Helena Eriksson, Birgitta Sparre, Helén Tuvesson, Oliver Distler

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Fingeravtryck

Fördjupa i forskningsämnen för ”An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod”. Tillsammans bildar de ett unikt fingeravtryck.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science